一个随机试验的患者导航与症状监测在晚期的肺癌
Kumar Prabhash1, Vanita Noronha1, Vijay Patil2
1Department of Medical Oncology, Tata Memorial Centre, Homi Bhabha National Institute (HBNI), Mumbai, India.
概括
患者导航与症状监测显著加快了治疗的开始,并改善了晚期肺癌患者的治疗效果. 这种方法减少了急诊,但没有影响生活质量或生存结果.
科学领域:
- 癌症学
- 临床试验
- 患者护理管理
背景情况:
- 癌症治疗中的障碍需要支持性干预.
- 耐心的导航者可以减轻这些障碍.
- 症状监测在晚期肺癌治疗中的作用需要评估.
研究的目的:
- 评估患者导航与症状监测的影响.
- 评估晚期肺癌患者对生活质量 (QoL) 和护理的影响.
- 分析二次终点,包括治疗开始,遵守和存活.
主要方法:
- 随机对照试验涉及150名晚期肺癌成年患者.
- 干预组接受患者导航 (协调,安排,症状监测).
- 主要终点:12周后的QOL变化;次要终点:开始治疗的时间,非计划的检查,服药,存活率.
主要成果:
- 干预组的治疗开始时间显著缩短 (19 vs 28 天).
- 在干预组中,急诊/非计划性诊断的频率降低 (67% vs 88%) 和治疗遵守率提高 (85% vs 68%).
- 没有观察到QOL,性能状态,无进展生存期 (PFS) 或总生存期 (OS) 的显著差异.
结论:
- 通过对患者进行症状监测,改善了癌症治疗.
- 它加快了治疗的开始,提高了对医疗的遵守,并减少了计划外的医疗使用.
- 这种干预不会对患者的生活质量或生存产生负面影响.
更多相关视频
相关概念视频
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...


